Rogerio Malveira Barreto

Country representing

Brazil

Languages

Portuguese
English

Education

  • Universidade Federal do Ceara
  • Medical Degree

Current organisation

ADVMED

Current role

CEO and co-founder / physician

Skills and Expertise

Healthcare
Human rights
Project management
Social entrepreneurship
Teaching and training

Areas of interest

Business
Education
Health
Human Rights
Leadership

Website & Social Links

I am passionate about

Actions

The IFMSA spans 119 countries. We sponsor health projects, and I focused specifically on Human Rights and Peace. For two years, I was the Brazilian National Officer on Human Rights and Peace (NORP). At the beginning of my term, there were 24 local committees with the Human Rights area active. At the end, there were 50. During the term, I co-created a project against child abuse for, In Brazil, 1 in 3 women and 1 in 6 men were sexually abused during childhood. For 5 weeks, we engaged parents, children, teachers and health professionals to break the stigmas around child abuse conversation. We executed the project in 15 cities in Brazil, reaching more than 2,000 people. In med school, I was part of Academic Impact, a global initiative to promote the UN’s Global Goals. There, I chaired a Human Rights conference for the entire Universidade Federal do Ceara. Because many patients lack health literacy, they do not understand medical instructions clearly and often do not adhere to health treatments. This leads to hospitalizations and huge costs. In the US, it costs $60 billion. Because there is, basically, no information on this in Brazil despite the fact there are 28 million functional illiterate people, I had an idea: create a software for health professionals that would generate a new model of medical prescription. This new model is organized by time of intake and uses simple images. It clearly shows how, when, and which medication to use. It improves both treatment adherence and patient-doctor relationship. We prototyped this ADVMED software in a public hospital for 2 months. Its final version will be available the first week of August, with dozens of doctors awaiting this fundamental health care improvement.